- Home
- MTUS vs DNTH Comparison
MTUS vs DNTH Comparison
Compare MTUS & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTUS
- DNTH
- Stock Information
- Founded
- MTUS 1899
- DNTH 2015
- Country
- MTUS United States
- DNTH United States
- Employees
- MTUS N/A
- DNTH 78
- Industry
- MTUS
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- MTUS
- DNTH Health Care
- Exchange
- MTUS NYSE
- DNTH Nasdaq
- Market Cap
- MTUS 699.0M
- DNTH 657.0M
- IPO Year
- MTUS N/A
- DNTH N/A
- Fundamental
- Price
- MTUS $12.87
- DNTH $21.67
- Analyst Decision
- MTUS
- DNTH Strong Buy
- Analyst Count
- MTUS 0
- DNTH 8
- Target Price
- MTUS N/A
- DNTH $54.33
- AVG Volume (30 Days)
- MTUS 323.1K
- DNTH 420.2K
- Earning Date
- MTUS 05-08-2025
- DNTH 05-08-2025
- Dividend Yield
- MTUS N/A
- DNTH N/A
- EPS Growth
- MTUS N/A
- DNTH N/A
- EPS
- MTUS 0.03
- DNTH N/A
- Revenue
- MTUS $1,084,000,000.00
- DNTH $6,235,000.00
- Revenue This Year
- MTUS $9.13
- DNTH N/A
- Revenue Next Year
- MTUS $10.82
- DNTH N/A
- P/E Ratio
- MTUS $424.67
- DNTH N/A
- Revenue Growth
- MTUS N/A
- DNTH 120.63
- 52 Week Low
- MTUS $10.78
- DNTH $13.37
- 52 Week High
- MTUS $24.31
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- MTUS 47.12
- DNTH 60.23
- Support Level
- MTUS $12.65
- DNTH $18.65
- Resistance Level
- MTUS $13.90
- DNTH $23.69
- Average True Range (ATR)
- MTUS 0.61
- DNTH 1.85
- MACD
- MTUS 0.13
- DNTH 0.65
- Stochastic Oscillator
- MTUS 66.99
- DNTH 80.43
About MTUS METALLUS INC
Metallus Inc is an America-based manufacturer of alloy steel, as well as carbon and micro-alloy steel. The portfolio of the company includes special bar quality steel, seamless mechanical tubes, and value-add solutions, such as precision steel components. The company also supplies machining and thermal treatment services and manages raw material recycling programs that work as a feeder system for its melt operations. The company's products and services are used in the following sectors: oil and gas; automotive; industrial equipment; mining; construction; rail; aerospace and defense; heavy truck; agriculture; and power generation. Geographically, the company mainly serves customers in the United States.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.